Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK39297 in Lupus Nephritis
NCT07363460Phase 2Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciprocopan in lupus nephritis (LN), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Nov 2025; status: recruiting.
02
Drugs
ciprocopan
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT07363460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07363460.